Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read an analysis of HUM stock now.

Besides Wall Street's top-and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

Humana Inc. (HUM) raised its full-year earnings outlook on Wednesday after reporting better-than-expected results for the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

Humana’s stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana ( (HUM)) has shared an announcement. Humana Inc. reported its financial results for the second quarter of 2025, highlighting a GAAP earnings per share (EPS) of $4.51 and an adjusted EPS of ...

In its earnings release, Humana Inc. (NYSE:HUM) said revenues increased by 9.6 percent in the second quarter of the year at ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

The S&P 500 fell 0.1% on Wednesday, July 30, 2025, as the Fed held interest rates steady and policymakers expressed concerns ...

CVS beats Q2 earnings and revenue estimates, lifts full-year forecast. Stock surges over 8% in premarket trading, up 39% YTD.

U.S. stock indexes are drifting on Wednesday after the Federal Reserve decided to keep interest rates where they are.